Profilo
Inger Sandlie is the founder of Nykode Therapeutics ASA, founded in 2006, and Nextera AS, founded in 2009.
At Nextera AS, she held the title of Scientific Advisor.
Currently, Dr. Sandlie holds the position of Director at Radiumhospitalets Forskningsstiftelse and the title of Professor at the University of Oslo.
Posizioni attive di Inger Sandlie
| Società | Posizione | Inizio |
|---|---|---|
Radiumhospitalets Forskningsstiftelse
Radiumhospitalets Forskningsstiftelse Financial ConglomeratesFinance Invests in companies from Nordic research institutions | Direttore/Membro del Consiglio | - |
University of Oslo
University of Oslo Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
Precedenti posizioni note di Inger Sandlie
| Società | Posizione | Fine |
|---|---|---|
| NYKODE THERAPEUTICS | Fondatore | - |
Nextera AS
Nextera AS Miscellaneous Commercial ServicesCommercial Services Provides drug research for therapeutic interventions for autoimmune diseases, chronic infections, and cancer | Fondatore | - |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 4 |
|---|---|
Radiumhospitalets Forskningsstiftelse
Radiumhospitalets Forskningsstiftelse Financial ConglomeratesFinance Invests in companies from Nordic research institutions | Finance |
University of Oslo
University of Oslo Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Nykode Therapeutics ASA
Nykode Therapeutics ASA Pharmaceuticals: MajorHealth Technology Develops vaccines and immunotherapy against infectious diseases and cancer | Health Technology |
Nextera AS
Nextera AS Miscellaneous Commercial ServicesCommercial Services Provides drug research for therapeutic interventions for autoimmune diseases, chronic infections, and cancer | Commercial Services |
















